Therefore, INTS8 was identified as a therapeutic target in CHOL and pan-cancer series; an association was observed between INTS8 expression and TIICs; MMR genes and DNMTs were suggested to mediate INTS8 effects. The gene discussed is MRC1; the disease is cancer.